J&J, Bayer, and Pfizer Layoffs: Nearly 500 Jobs Cut Amid Restructuring

Johnson & Johnson has announced a significant reduction of 231 jobs at its New Brunswick headquarters in New Jersey. This move is part of a broader organizational restructuring effort designed to adapt to a rapidly changing global environment and address evolving patient needs[1][2][3]. The layoffs are effective by the end of December, as part of J&J's strategy to become more agile in a competitive market landscape[2]. This decision also aligns with J&J's ongoing adaptations amid challenges such as controversies around the 340B program and patent expirations for key products[2].